NO925038L - Anordning for nedsettelse av medikamentets hudirriterendevirkninger - Google Patents

Anordning for nedsettelse av medikamentets hudirriterendevirkninger

Info

Publication number
NO925038L
NO925038L NO92925038A NO925038A NO925038L NO 925038 L NO925038 L NO 925038L NO 92925038 A NO92925038 A NO 92925038A NO 925038 A NO925038 A NO 925038A NO 925038 L NO925038 L NO 925038L
Authority
NO
Norway
Prior art keywords
drug
irritation
skin
mucosa
human
Prior art date
Application number
NO92925038A
Other languages
English (en)
Norwegian (no)
Other versions
NO925038D0 (no
Inventor
Michel J-N Cormier
Philip W Ledger
Alfred Amkraut
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Publication of NO925038D0 publication Critical patent/NO925038D0/no
Publication of NO925038L publication Critical patent/NO925038L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Packaging For Recording Disks (AREA)
  • Passenger Equipment (AREA)
NO92925038A 1990-07-06 1992-12-30 Anordning for nedsettelse av medikamentets hudirriterendevirkninger NO925038L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/549,584 US5130139A (en) 1990-07-06 1990-07-06 Reduction or prevention of skin irritation by drugs
PCT/US1991/004685 WO1992000746A1 (fr) 1990-07-06 1991-07-01 Reduction ou prevention de l'irritation de la peau par des medicaments

Publications (2)

Publication Number Publication Date
NO925038D0 NO925038D0 (no) 1992-12-30
NO925038L true NO925038L (no) 1993-01-06

Family

ID=24193593

Family Applications (1)

Application Number Title Priority Date Filing Date
NO92925038A NO925038L (no) 1990-07-06 1992-12-30 Anordning for nedsettelse av medikamentets hudirriterendevirkninger

Country Status (18)

Country Link
US (1) US5130139A (fr)
EP (1) EP0538302B1 (fr)
JP (1) JP3224814B2 (fr)
AT (1) ATE121627T1 (fr)
AU (1) AU641787B2 (fr)
CA (1) CA2046014C (fr)
DE (1) DE69109292T2 (fr)
DK (1) DK0538302T3 (fr)
ES (1) ES2071322T3 (fr)
FI (1) FI930038A7 (fr)
GR (1) GR3015934T3 (fr)
IE (1) IE74152B1 (fr)
MX (1) MX9100042A (fr)
NO (1) NO925038L (fr)
NZ (1) NZ238804A (fr)
PT (1) PT98177B (fr)
WO (1) WO1992000746A1 (fr)
ZA (1) ZA915067B (fr)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0566740B1 (fr) * 1991-11-08 2000-11-29 Welfide Corporation Utilisation des iso-thiocyanates dans un adhesif autocollant bactericide
US5843979A (en) * 1993-02-25 1998-12-01 Bristol-Myers Squibb Company Transdermal treatment with mast cell degranulating agents for drug-induced hypersensitivity
US6190894B1 (en) 1993-03-19 2001-02-20 The Regents Of The University Of California Method and compositions for disrupting the epithelial barrier function
IL109036A (en) * 1993-03-19 1998-12-27 Cellegy Pharamaceuticals Inc Preparations for detachment of the epithelial barrier function and use of means for the preparation of such preparations
US5451407A (en) * 1993-06-21 1995-09-19 Alza Corporation Reduction or prevention of skin irritation or sensitization during transdermal administration of a irritating or sensitizing drug
DK0752898T3 (da) 1994-03-30 1999-02-15 Alza Corp Mindskning af hudirritation ved elektrotransport-tilførsel
WO1995034262A1 (fr) * 1994-06-16 1995-12-21 Department Of The Army, Us Government Traitement transdermique du paludisme
US5686100A (en) * 1994-11-22 1997-11-11 E.R. Squibb & Sons, Inc. Prophylactic and therapeutic treatment of skin sensitization and irritation
WO1997047355A1 (fr) * 1996-06-12 1997-12-18 Alza Corporation Reduction de la sensibilisation de la peau lors de l'administration d'un medicament par electrotransport
US6512010B1 (en) * 1996-07-15 2003-01-28 Alza Corporation Formulations for the administration of fluoxetine
US5981168A (en) 1998-05-15 1999-11-09 The University Of British Columbia Method and composition for modulating amyloidosis
US6699497B1 (en) * 1998-07-24 2004-03-02 Alza Corporation Formulations for the transdermal administration of fenoldopam
US20040258742A1 (en) * 2003-04-11 2004-12-23 Van Osdol William Woodson Transdermal administration of N-(2,5-disubstituted phenyl)-N'-(3-substituted phenyl)-N'-methyl guanidines
US8252321B2 (en) 2004-09-13 2012-08-28 Chrono Therapeutics, Inc. Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like
AU2005284908B2 (en) 2004-09-13 2011-12-08 Morningside Venture Investments Limited Biosynchronous transdermal drug delivery
US20070042026A1 (en) * 2005-03-17 2007-02-22 Wille John J Prophylactic and therapeutic treatment of topical and transdermal drug-induced skin reactions
WO2006127905A2 (fr) 2005-05-24 2006-11-30 Chrono Therapeutics, Inc. Dispositif d'apport de medicament portatif comprenant un element de dosage et d'administration detachable et remplaçable
JP2010516556A (ja) 2007-01-25 2010-05-20 本田技研工業株式会社 車両の安定性を改善するための車両システムの制御方法
WO2013006643A1 (fr) 2011-07-06 2013-01-10 The Parkinson's Institute Compositions et méthodes de traitement de symptômes chez des patients atteints de la maladie de parkinson
US10105487B2 (en) 2013-01-24 2018-10-23 Chrono Therapeutics Inc. Optimized bio-synchronous bioactive agent delivery system
CN105492004A (zh) * 2013-02-08 2016-04-13 罗达制药有限公司 治疗局部微生物感染的方法
AU2016211330A1 (en) 2015-01-28 2017-08-03 Chrono Therapeutics Inc. Drug delivery methods and systems
US10679516B2 (en) 2015-03-12 2020-06-09 Morningside Venture Investments Limited Craving input and support system
CA3049529A1 (fr) 2017-01-06 2018-07-12 Chrono Therapeutics Inc. Dispositifs et methodes d'administration transdermique de medicament
US11596779B2 (en) 2018-05-29 2023-03-07 Morningside Venture Investments Limited Drug delivery methods and systems
US12397141B2 (en) 2018-11-16 2025-08-26 Morningside Venture Investments Limited Thermally regulated transdermal drug delivery system

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3598122A (en) * 1969-04-01 1971-08-10 Alza Corp Bandage for administering drugs
US3598123A (en) * 1969-04-01 1971-08-10 Alza Corp Bandage for administering drugs
US3991755A (en) * 1973-07-27 1976-11-16 Medicon, Inc. Iontophoresis apparatus for applying local anesthetics
US4274420A (en) * 1975-11-25 1981-06-23 Lectec Corporation Monitoring and stimulation electrode
US4141359A (en) * 1976-08-16 1979-02-27 University Of Utah Epidermal iontophoresis device
US4325367A (en) * 1977-06-13 1982-04-20 Robert Tapper Iontophoretic treatment apparatus
US4250878A (en) * 1978-11-22 1981-02-17 Motion Control, Inc. Non-invasive chemical species delivery apparatus and method
CA1153427A (fr) * 1978-12-11 1983-09-06 Patrick T. Cahalan Electrode auto-collable
BR8008859A (pt) * 1979-10-10 1981-08-25 Cyclotech Med Ind Bandagem bloqueadora de dor
US4286592A (en) * 1980-02-04 1981-09-01 Alza Corporation Therapeutic system for administering drugs to the skin
US4314557A (en) * 1980-05-19 1982-02-09 Alza Corporation Dissolution controlled active agent dispenser
US4379454A (en) * 1981-02-17 1983-04-12 Alza Corporation Dosage for coadministering drug and percutaneous absorption enhancer
JPS5810066A (ja) * 1981-07-10 1983-01-20 株式会社アドバンス イオントフオレ−ゼ用プラスタ−構造体
US4419092A (en) * 1981-11-06 1983-12-06 Motion Control, Inc. Iontophoretic electrode structure
GB2124485B (en) * 1982-08-04 1986-06-04 Michael A Levy Penetrating topical medicament
US4559222A (en) * 1983-05-04 1985-12-17 Alza Corporation Matrix composition for transdermal therapeutic system
US4557723A (en) * 1983-08-18 1985-12-10 Drug Delivery Systems Inc. Applicator for the non-invasive transcutaneous delivery of medicament
US4640689A (en) * 1983-08-18 1987-02-03 Drug Delivery Systems Inc. Transdermal drug applicator and electrodes therefor
US4708716A (en) * 1983-08-18 1987-11-24 Drug Delivery Systems Inc. Transdermal drug applicator
US4573995A (en) * 1984-10-09 1986-03-04 Alza Corporation Transdermal therapeutic systems for the administration of naloxone, naltrexone and nalbuphine
US4702732A (en) * 1984-12-24 1987-10-27 Trustees Of Boston University Electrodes, electrode assemblies, methods, and systems for tissue stimulation and transdermal delivery of pharmacologically active ligands
FR2605221B1 (fr) * 1986-10-20 1989-09-01 Sanofi Sa Compositions pharmaceutiques ou veterinaires contenant de la de(hydroxymethyl)-25 deoxy-25 oxo-25 monensine
AU610839B2 (en) * 1986-11-07 1991-05-30 Purepac, Inc Transdermal administration of amines
US4983395A (en) * 1987-11-12 1991-01-08 Theratech Inc. Device for administering an active agent to the skin or mucosa
US4885154A (en) * 1988-03-01 1989-12-05 Alza Corporation Method for reducing sensitization or irritation in transdermal drug delivery and means therefor
US4855294A (en) * 1988-09-06 1989-08-08 Theratech, Inc. Method for reducing skin irritation associated with drug/penetration enhancer compositions
US4908213A (en) * 1989-02-21 1990-03-13 Schering Corporation Transdermal delivery of nicotine
IL94768A (en) * 1989-06-19 1995-08-31 Wellcome Found Use of aryl-substituted amine derivatives in the preparation of pharmaceutical compositions

Also Published As

Publication number Publication date
FI930038L (fi) 1993-01-05
DK0538302T3 (da) 1995-09-18
IE912294A1 (en) 1992-01-15
CA2046014A1 (fr) 1992-01-07
ES2071322T3 (es) 1995-06-16
ATE121627T1 (de) 1995-05-15
NO925038D0 (no) 1992-12-30
MX9100042A (es) 1992-02-28
ZA915067B (en) 1992-04-29
IE74152B1 (en) 1997-07-02
PT98177A (pt) 1993-08-31
EP0538302B1 (fr) 1995-04-26
WO1992000746A1 (fr) 1992-01-23
NZ238804A (en) 1992-08-26
JPH05508643A (ja) 1993-12-02
US5130139A (en) 1992-07-14
EP0538302A1 (fr) 1993-04-28
DE69109292D1 (de) 1995-06-01
PT98177B (pt) 1998-12-31
GR3015934T3 (en) 1995-07-31
AU641787B2 (en) 1993-09-30
JP3224814B2 (ja) 2001-11-05
CA2046014C (fr) 2003-05-20
DE69109292T2 (de) 1995-08-31
AU8104691A (en) 1992-02-04
FI930038A0 (fi) 1993-01-05
FI930038A7 (fi) 1993-01-05

Similar Documents

Publication Publication Date Title
NO925038D0 (no) Anordning for nedsettelse av medikamentets hudirriterendevirkninger
WO1992002234A3 (fr) Reduction ou prevention du phenomene de sensibilisation aux medicaments
ATE429904T1 (de) Topisch anwendbare arzneipräparate und verfahren zur behandlung
NZ508526A (en) Opioid formulations for treating pain
ATE292982T1 (de) Analgesiche synergie durch gleichzeitige verabreichung von subanalgesichen doseneines mu- opioidanagonisten und eines kappa - 2- opioidanagonisten
TR200103613T2 (tr) Burun içinden tatbik edilen morfini içeren farmasötik formülasyonlar ve yöntemler.
BR9306841A (pt) Composição farmacêutica processo para proporcionar um tratamento anti-histamínico o qual não induz qualquer arritmia cardíaca significativa em um paciente ser humano e uso de uma composição para a mnaufactura de um medicamento para uso em um tratamento anti-histamínico
NO944249L (no) Transdermal administrering av oksybutynin
GR3032523T3 (en) Therapeutic preparation for the transdermal administration of active substances
BR0013540A (pt) Formulações farmacêuticas e seu uso na prevenção de acidente vascular cerebral, diabetes e/ou falha de coração congestiva
EP1441799A4 (fr) Dispositif et procede d'administration de microdoses d'agents dans l'oreille
WO1994008551A3 (fr) Procedes et compositions pharmaceutiques destines au traitement des symptomes du rhume
SE9601528D0 (sv) Transdermally administered dextromethorphan as antitissue agent
ATE141045T1 (de) Schlankmachende zusammensetzung
EP0799618A3 (fr) Utilisation d'antagonistes de l'adrénorécepteur alpha 1 dans la fabrication d'unmédicament pur la prévention et au traitment du cancer
BR0311180A (pt) Métodos para o tratamento de doenças e condições respiratórias utilizando um inibidor seletivo da inos
HUP9901935A2 (hu) Gyógyszerek és terápiás szerek és más glikozaminoglikánok (GAG) dózisainak célbajuttatására alkalmas dóziskészlet
WO2001041771A3 (fr) Systeme transdermique contenant de l'acide acetylsalicylique pour le traitement de la migraine
Santoro et al. Assessment of skin safety of a new glyceryl trinitrate transdermal patch
NO961180L (no) Transdermal anordning inneholdende (E)-2-(p-fluorfenetyl)-3-fluorallylamin for behandling av Alzheimers sykdom
IL110888A (en) Pharmaceutical compositions for the treatment of liver diseases comprising a vasodilating compound
EP0987022A4 (fr) Medicaments de prevention ou de traitement de la recto-colite hemorragique et/ou de la maladie de crohn